E Ehrnrooth Selected Research

E Ehrnrooth Research Topics

4	Neoplasms (Cancer) 10/2017 - 01/2000
4	Colorectal Neoplasms (Colorectal Cancer) 02/2012 - 01/2000
3	Squamous Cell Carcinoma of Head and Neck 10/2017 - 09/2014
3	Stomatitis 01/2016 - 02/2012
2	Head and Neck Neoplasms (Head and Neck Cancer) 10/2017 - 01/2001
2	Acne Vulgaris 01/2016 - 09/2014
2	Diarrhea 01/2016 - 09/2014
2	Exanthema (Rash) 01/2016 - 09/2014
2	Pain (Aches) 01/2016 - 01/2001
2	Mucositis 09/2014 - 01/2001
1	Fatigue 01/2016
1	Disease Progression 09/2014
1	Lung Neoplasms (Lung Cancer) 09/2014
1	Nausea 02/2012
1	Vomiting 02/2012
1	Lymphopenia (Lymphocytopenia) 02/2012
1	Lethargy 02/2012
1	Fever (Fevers) 02/2012
1	Neuralgia (Stump Neuralgia) 01/2001
1	Rheumatoid Arthritis 11/2000

4	AfatinibIBA 10/2017 - 05/2013
3	PlatinumIBA 10/2017 - 09/2014
3	Methotrexate (Mexate)FDA LinkGeneric 10/2017 - 11/2000
2	Pharmaceutical PreparationsIBA 09/2014 - 05/2013
2	Cetuximab (Erbitux)FDA Link 09/2014 - 02/2012
2	Fluorouracil (Carac)FDA LinkGeneric 05/2013 - 01/2000
2	Thymidylate SynthaseIBA 01/2000 - 01/2000
2	Messenger RNA (mRNA)IBA 01/2000 - 01/2000
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	Blood Proteins (Serum Proteins)IBA 10/2017
1	Tumor Biomarkers (Tumor Markers)IBA 10/2017
1	ErbB Receptors (EGF Receptor)IBA 09/2014
1	Cisplatin (Platino)FDA LinkGeneric 05/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2013
1	interleukin-21 (interleukin 21)IBA 02/2012
1	Cytotoxins (Cytolysins)IBA 01/2008
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2008
1	Capecitabine (Xeloda)FDA Link 01/2008
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2008
1	Morphine (MS Contin)FDA LinkGeneric 01/2001
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2001
1	Opioid Analgesics (Opioids)IBA 01/2001
1	Analgesics (Analgesic Drugs)IBA 01/2001
1	Antineoplastic Agents (Antineoplastics)IBA 01/2000
1	EnzymesIBA 01/2000